104 related articles for article (PubMed ID: 21163253)
1. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
3. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
[TBL] [Abstract][Full Text] [Related]
4. CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells.
Nishida H; Yamazaki H; Yamada T; Iwata S; Dang NH; Inukai T; Sugita K; Ikeda Y; Morimoto C
Biochem Biophys Res Commun; 2009 Apr; 382(1):57-62. PubMed ID: 19254692
[TBL] [Abstract][Full Text] [Related]
5. Characterization of side population cells in human malignant mesothelioma cell lines.
Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract][Full Text] [Related]
7. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
Ferletta M; Grawé J; Hellmén E
Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.
Amatya VJ; Takeshima Y; Kushitani K; Yamada T; Morimoto C; Inai K
Oncol Rep; 2011 Dec; 26(6):1369-75. PubMed ID: 21894438
[TBL] [Abstract][Full Text] [Related]
9. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
[TBL] [Abstract][Full Text] [Related]
10. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
11. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.
Okamoto T; Iwata S; Yamazaki H; Hatano R; Komiya E; Dang NH; Ohnuma K; Morimoto C
PLoS One; 2014; 9(1):e86671. PubMed ID: 24466195
[TBL] [Abstract][Full Text] [Related]
12. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
[TBL] [Abstract][Full Text] [Related]
13. CD26 a cancer stem cell marker and therapeutic target.
Davies S; Beckenkamp A; Buffon A
Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
[TBL] [Abstract][Full Text] [Related]
14. Induction characterization and targeting of human hematopoietic cancer stem cells.
Zhang M; Dias P; Minev B; Koka PS
J Stem Cells; 2010; 5(1):1-7. PubMed ID: 20861923
[TBL] [Abstract][Full Text] [Related]
15. Evidence for cancer stem cells in human endometrial carcinoma.
Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
[TBL] [Abstract][Full Text] [Related]
16. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
[TBL] [Abstract][Full Text] [Related]
18. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
19. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions.
Inagaki A; Soeda A; Oka N; Kitajima H; Nakagawa J; Motohashi T; Kunisada T; Iwama T
Biochem Biophys Res Commun; 2007 Sep; 361(3):586-92. PubMed ID: 17673180
[TBL] [Abstract][Full Text] [Related]
20. CD24(-/low) stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability.
Bensimon J; Altmeyer-Morel S; Benjelloun H; Chevillard S; Lebeau J
Oncogene; 2013 Jan; 32(2):251-8. PubMed ID: 22330142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]